178 related articles for article (PubMed ID: 3646180)
1. The elimination of gentamicin-resistant gram-negative bacteria in a newborn intensive care unit.
Raz R; Sharir R; Shmilowitz L; Kenes I; Ephros M
Infection; 1987; 15(1):32-4. PubMed ID: 3646180
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.
Bryan CS; John JF; Pai MS; Austin TL
Am J Dis Child; 1985 Nov; 139(11):1086-9. PubMed ID: 3904403
[TBL] [Abstract][Full Text] [Related]
3. Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae.
de Champs C; Franchineau P; Gourgand JM; Loriette Y; Gaulme J; Sirot J
J Hosp Infect; 1994 Nov; 28(3):219-29. PubMed ID: 7852735
[TBL] [Abstract][Full Text] [Related]
4. Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
Wielunsky E; Drucker M; Cohen T; Reisner SH
Isr J Med Sci; 1983 Nov; 19(11):1006-8. PubMed ID: 6662682
[TBL] [Abstract][Full Text] [Related]
5. Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
Thomson KM; Dyer C; Liu F; Sands K; Portal E; Carvalho MJ; Barrell M; Boostrom I; Dunachie S; Farzana R; Ferreira A; Frayne F; Hassan B; Jones E; Jones L; Mathias J; Milton R; Rees J; Chan GJ; Bekele D; Mahlet A; Basu S; Nandy RK; Saha B; Iregbu K; Modibbo F; Uwaezuoke S; Zahra R; Shirazi H; Syed NU; Mazarati JB; Rucogoza A; Gaju L; Mehtar S; Bulabula ANH; Whitelaw A; van Hasselt JGC; Walsh TR;
Lancet Infect Dis; 2021 Dec; 21(12):1677-1688. PubMed ID: 34384533
[TBL] [Abstract][Full Text] [Related]
6. Changing trend of empirical antibiotic regimen: experience of two studies at different periods in a neonatal intensive care unit in Tehran, Iran.
Marzban A; Samaee H; Mosavinasab N
Acta Med Iran; 2010; 48(5):312-5. PubMed ID: 21287464
[TBL] [Abstract][Full Text] [Related]
7. Five-year surveillance of aminoglycoside usage in a university hospital.
Betts RF; Valenti WM; Chapman SW; Chonmaitree T; Mowrer G; Pincus P; Messner M; Robertson R
Ann Intern Med; 1984 Feb; 100(2):219-22. PubMed ID: 6691664
[TBL] [Abstract][Full Text] [Related]
8. Five years of cefotaxime use in a neonatal intensive care unit.
Spritzer R; vd Kamp HJ; Dzoljic G; Sauer PJ
Pediatr Infect Dis J; 1990 Feb; 9(2):92-6. PubMed ID: 2179846
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial therapy of bacterial sepsis in the newborn infant.
Starr SE
J Pediatr; 1985 Jun; 106(6):1043-8. PubMed ID: 3889254
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance patterns during aminoglycoside restriction.
Young EJ; Sewell CM; Koza MA; Clarridge JE
Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of three antibiotic programs in newborn infants.
Marks S; Marks MI; Dupont C; Hammerberg S
Can Med Assoc J; 1978 Mar; 118(6):659-62. PubMed ID: 657058
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.
Modi N; Damjanovic V; Cooke RW
Arch Dis Child; 1987 Feb; 62(2):148-51. PubMed ID: 3827292
[TBL] [Abstract][Full Text] [Related]
13. Enterobacter aerogenes outbreak in a neonatal intensive care unit.
Loiwal V; Kumar A; Gupta P; Gomber S; Ramachandran VG
Pediatr Int; 1999 Apr; 41(2):157-61. PubMed ID: 10221019
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis.
Metsvaht T; Ilmoja ML; Parm Ü; Maipuu L; Merila M; Lutsar I
Acta Paediatr; 2010 May; 99(5):665-672. PubMed ID: 20096030
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella.
Noriega ER; Leibowitz RE; Richmond AS; Rubinstein E; Schaefler S; Simberkoff MS; Rahal JJ
J Infect Dis; 1975 May; 131 Suppl():S45-50. PubMed ID: 1092773
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Leonard JM; McGee ZA; Alford RH
Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin-resistant Enterobacteriaceae in a neonatal intensive care unit.
Balslev T; Kristensen B; Ebbesen F; Schumacher H; Korsager B
Acta Paediatr; 1993 Sep; 82(9):792-3. PubMed ID: 8241680
[No Abstract] [Full Text] [Related]
18. An outbreak of gentamicin-resistant Enterobacter cloacae infections in a pediatric intensive care unit.
Anderson EL; Hieber JP
Infect Control; 1983; 4(3):148-52. PubMed ID: 6553023
[TBL] [Abstract][Full Text] [Related]
19. Bacterial agents in neonatal septicaemia in Calabar, Nigeria (a review of 100 cases).
Antia-Obong OE; Utsalo SJ
West Afr J Med; 1993; 12(2):114-7. PubMed ID: 8398930
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin treatment associated with later nosocomial gentamicin-resistant Serratia marcescens infections.
Graham DR; Clegg HW; Anderson RL; Chelgren GA; Mostow SR; Dixon RE
Infect Control; 1981; 2(1):31-7. PubMed ID: 7012063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
